Overview
Description
Lobe Sciences Ltd. operates in the healthcare and biotechnology sectors, focusing on transforming the field of mental health treatment. The company is invested in developing innovative therapies and devices designed to improve brain and mental health disorders. Through its research and development initiatives, Lobe Sciences is exploring the use of novel psychedelic compounds and drug delivery mechanisms to address critical needs in neurological and psychiatric care. As part of its strategic operations, the company integrates advanced scientific research with technology to create effective treatment solutions. Lobe Sciences Ltd. plays a crucial role in the burgeoning field of psychedelic therapeutics, which is gaining attention for its potential to revolutionize mental health care and improve patient outcomes. The company is dedicated to advancing scientific understanding and expanding the therapeutic potential of psychedelics within regulated environments.
About
CEO
Dr. Frederick Dominick Sancilio M.S., Ph.D.
Employees
0
Address
1771 Robson Street
Suite 1614
Vancouver, V6G 3B7, BC
Canada
Suite 1614
Vancouver, V6G 3B7, BC
Canada
Phone
949-505-5623
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
PINX